David M. Brown
Active 1973–2025
- Also published as
- DAVID M. BROWN · David M Brown
- 167
- Papers
- 47,846
- Citations
- 99
- h-index
- 158
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine66.8%
- Biochemistry, Genetics and Molecular Biology12%
- Environmental Science6.9%
- Materials Science6.3%
- Immunology and Microbiology2.8%
- Neuroscience1.3%
- Other3.9%
Topics
- Retinal Diseases and Treatments16.7%
- Retinal Imaging and Analysis6.7%
- Ocular Diseases and Behçet’s Syndrome5.1%
- Ophthalmology and Visual Impairment Studies4%
- Retinal and Optic Conditions3.3%
- Retinal Development and Disorders2.7%
- Other61.5%
Coauthors
- Charles C. Wykoff37
- Jeffrey S. Heier35
- David S. Boyer33
- Vicki Stone19
- Robert Vitti17
- Alyson J. Berliner15
- Quan Dong Nguyen15
- Peter K. Kaiser14
- William MacNee14
- Peter A. Campochiaro13
- Ken Donaldson11
- Prema Abraham11
- W. Lloyd Clark11
- Kenneth Donaldson10
- Michael W. Steffes10
- S. Michael Mauer10
- Dennis M. Marcus9
- Frank G. Holz9
- George D. Yancopoulos9
- Glenn J. Jaffe9
- Srinivas R. Sadda9
- Justis P. Ehlers8
- Oliver Zeitz8
- Thomas Schmelter8
All papers
- Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Authors: Jeffrey S Heier, Jeffrey S Heier, Arshad M Khanani, Carlos Quezada Ruiz, Karen Basu, Philip J Ferrone, Christopher Brittain, Marta S Figueroa, Hugh Lin, Frank G Holz, Vaibhavi Patel, Timothy Y Y Lai, David Silverman, Carl Regillo, Balakumar Swaminathan, Francesco Viola, Chui Ming Gemmy Cheung, Tien Y Wong, Ashkan Abbey, Elmira Abdulaeva, Prema Abraham, Alfredo Adan Civera, Hansjurgen Agostini, Arturo Alezzandrini, Virgil Alfaro, Arghavan Almony, Lebriz Altay, Payam Amini, Andrew Antoszyk, Etelka Aradi, Luis Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Jr. Z Bridges, Jamin Brown, David M. Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Iksoo Byon, Carlo Cagini, Jorge Calzada, Stone Cameron, Peter Campochiaro, John Carlson, Angela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih-Jen Chen, San-Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David Chow, Abosede Cole, Brian Connolly, Pierre Loic Cornut, Stephen Couvillion, Carl Danzig, Vesselin Daskalov, Amr Dessouki, Francois Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard Dreyer, Pravin Dugel, David Eichenbaum, Bora Eldem, Robert Engstrom, Joan Josep Escobar, Nicole Eter, David W. Faber, Naomi Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip Ferrone, Marta Figueroa, Howard Fine, Mitchell Fineman, Gregory M. Fox, Catherine Francais, Pablo Franco, Samantha Fraser-Bell, Nicholas Fung, Federico Furno Sola and 218 more - The Lancet 2022 cited by 686
- Ranibizumab for Neovascular Age-Related Macular Degeneration
Authors: Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier, David S. Boyer, Peter K. Kaiser, Carol Chung, Robert Y. Kim - New England Journal of Medicine 2006 cited by 5,866
- Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Authors: Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz, Philip J. Rosenfeld, Robyn H. Guymer, David S. Boyer, F Grossi, Caroline R. Baumal, Jean‐François Korobelnik, Jason S. Slakter, Nadia K. Waheed, Ravi Metlapally, Ian Pearce, Nathan Steinle, A Francone, Allen Hu, David R. Lally, Pascal Deschatelets, Cedric Francois, Caleb Bliss, Giovanni Staurenghi, Jordi Monés, Rishi P. Singh, Ramiro Ribeiro, Charles C. Wykoff, Abosede O Cole, Adam T. Gerstenblith, Ajay Kotagiri, Albert O. Edwards, Alberto D Zambrano, Alexander M. Eaton, Alexander Rubowitz, Alice T. Lyon, Allen Chiang, Allen C. Ho, Allen Hu, Amir Guerami, Amr Dessouki, André Corrêa Maia de Carvalho, Andrés Emanuelli, Andrew Chang, Andrew N. Antoszyk, A Francone, Anita Prasad, Armin Wolf, Arshad M. Khanani, Ashkan M. Abbey, Asma Moulana, Barbara Wihelm, Bartosz L. Sikorski, Baruch D. Kuppermann, Benjamin Wolff, Brian Jewart, K. Brian, Brian T. Chan-Kai, Calvin E. Mein, Carel B. Hoyng, Carl C. Awh, Carl Regillio, Carlos Zeolite, Caroline R. Baumal, Catherine Creuzot‐Garcher, Catherine Français Maury, Charles C. Wykoff, Charles K Newell, Chirag Jhaveri, Chris P. Lohmann, Christiana Dinah, Colin Ma, Courtney Crawford, D Wilkin Parke, Daniel Lavinsky, Daniel B. Roth, Dante J. Pieramici, Darius M. Moshfeghi, Darrin Levin, David A. Saperstein, David M. Brown, David Gaucher, David R. Lally, David Liao, David Warren Brown, Debra A. Goldstein, Dennis M. Marcus, Derek G. Chan, Dilsher S. Dhoot, Domingo Tacite, Dominik Zalewski, Edgar M. Espana, Eleonora M. Lad, Eric H. Souied, Eric Suan, Eva Eting, Federico Furno Sola, F. De Bats, Francesco Bandello, Francisco Gómez‐Ulla, François Devin, Frank G. Holz, Fred K. Chen and 163 more - The Lancet 2023 cited by 443
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Authors: Jeffrey S. Heier, David M. Brown, Victor Chong, Jean‐François Korobelnik, Peter K. Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen C. Ho, Yuichiro Ogura, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Georg Groetzbach, Bernd Sommerauer, Rupert Sandbrink, Christian Simader, Ursula Schmidt‐Erfurth - Ophthalmology 2012 cited by 2,470
- Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Authors: Charles C Wykoff, Charles C Wykoff, Francis Abreu, Anthony P Adamis, Karen Basu, David A Eichenbaum, Zdenka Haskova, Hugh Lin, Anat Loewenstein, Shaun Mohan, Ian A Pearce, Taiji Sakamoto, Patricio G Schlottmann, David Silverman, Jennifer K Sun, John A Wells, Jeffrey R Willis, Ramin Tadayoni, Thomas Aaberg, Ashkan Abbey, Elmira Abdulaeva, Santiago Abengoechea, Prema Abraham, Thomas Ach, Serrhel Adams, Alfredo Adan Civera, Sean Adrean, Hansjurgen Agostini, Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew Antoszyk, Luis Arias, Riaz Asaria, Marcos Avila, Carl C Awh, Joaquin Bafalluy, Carl Baker, Francesco Bandello, Mark Barakat, Karen Barraza, Gyorgy Bator, Caroline Baumal, Rubens Belfort Jr, Chris Bergstrom, George Bertolucci, Thomas Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Bordon, David Boyer, Galina Bratko, Michael Brent, Jamin Brown, David M Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge Calzada, Peter Campochiaro, John Carlson, Alessandro Castellarin, Carlos Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred Chen, Shih-Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David Chow, Brian Connolly, Pierre Loic Cornut, Karl Csaky, Carl Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John Dickinson, Brian Do, Michael Dollin, Pravin Dugel, Jaroslava Dusova, David Eichenbaum and 296 more - The Lancet 2022 cited by 435
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Authors: Pravin U. Dugel, Adrian Koh, Yuichiro Ogura, Glenn J. Jaffe, Ursula Schmidt‐Erfurth, David M. Brown, André Vieira Gomes, James Warburton, Andreas Weichselberger, Frank G. Holz - Ophthalmology 2019 cited by 911
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Authors: David Liao, F Grossi, Delphine El Mehdi, Monica Gerber, David M. Brown, Jeffrey S. Heier, Charles C. Wykoff, Lawrence J. Singerman, Prema Abraham, Felix Graßmann, Peter Nüernberg, Bernhard H. F. Weber, Pascal Deschatelets, Robert Y. Kim, Carol Chung, Ramiro Ribeiro, Mohamed Hamdani, Philip J. Rosenfeld, David S. Boyer, Jason S. Slakter, Cedric Francois - Ophthalmology 2019 cited by 512
- Vaccination induces HIV broadly neutralizing antibody precursors in humans
Authors: David J. Leggat, Kristen W. Cohen, Jordan R. Willis, William J. Fulp, Allan C. deCamp, Oleksandr Kalyuzhniy, Christopher A. Cottrell, Sergey Menis, Greg Finak, Lamar Ballweber-Fleming, Abhinaya Srikanth, Jason R. Plyler, Torben Schiffner, Alessia Liguori, Farhad Rahaman, Angela Lombardo, Vincent Philiponis, Rachael E. Whaley, Aaron Seese, Joshua Brand, Alexis M. Ruppel, Wesley Hoyland, Nicole L. Yates, LaTonya D. Williams, Kelli Greene, Hongmei Gao, Celia R. Mahoney, Martin Corcoran, Alberto Cagigi, Alison Taylor, David M. Brown, David R. Ambrozak, Troy Sincomb, Xiaozhen Hu, Ryan Tingle, Erik Georgeson, Saman Eskandarzadeh, Nushin Alavi, Danny Lu, Tina-Marie Mullen, Michael Kubitz, Bettina Gröschel, Janine Maenza, Orpheus Kolokythas, Nadia J. Khati, Jeffrey M. Bethony, Shane Crotty, Mario Roederer, Gunilla B. Karlsson Hedestam, Georgia D. Tomaras, David C. Montefiori, David Diemert, Richard A. Koup, Dagna Laufer, M. Juliana McElrath, Adrian B. McDermott, William R. Schief - Science 2022 cited by 272
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Authors: David M. Brown, Peter K. Kaiser, Mark Michels, G. Soubrane, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, Susan Schneider - New England Journal of Medicine 2006 cited by 3,503
- Ranibizumab for Diabetic Macular Edema
Authors: Quan Dong Nguyen, David M. Brown, Dennis M. Marcus, David S. Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy P. Sy, Amy Chen Rundle, J. Jill Hopkins, Roman G. Rubio, Jason S. Ehrlich - Ophthalmology 2012 cited by 1,600
- Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression
Authors: Emily Y. Chew, Traci E. Clemons, Elvira Agrón, Amitha Domalpally, Tiarnán D L Keenan, Susan Vitale, Claire Weber, Douglas C. Smith, William G. Christen, John Paul SanGiovanni, Federick L Ferris, Ronald P. Danis, Barbara A. Blodi, Alan Ruby, Andrew N. Antoszyk, Ronald Klein, Ivana K. Kim, Gary E. Fish, Wai T. Wong, David H. Orth, Kourous A. Rezaei, Susan B. Bressler, GB Hubbard, Michael J. Elman, Suresh Chandra, Thomas R. Friberg, Michael Tolentino, Darmakusuma Le, Mary B. Lansing, Jay B. Stallman, Paul Edwards, Carl W. Baker, Michael Novák, Ricky D. Isernhagen, Todd E. Schneiderman, Lawrence S. Halperin, Michael H. Lee, David S. Boyer, Philip J. Rosenfeld, Pamela Rath, Marc H. Levy, Robert H. Rosa, John C. Hoskins, Clement K. Chan, David M. Brown, Craig M. Greven, J Michael Jumper, Linda J. Margulies, William N. Rosenthal, Richard B. Rosen, Glenn Stoller, Fadi El Baba, W. Copley McLean, Ronald Kingsley, Alice T. Lyon, Jeffrey S. Heier, Anne E. Fung, Ingrid U. Scott, John A. Wells, Michael J. Banach, Paul M. Beer, James C. Folk, Joseph I. Maguire, Srinivas R. Sadda, Richard A. Garfinkel, Judy E. Kim, Paul Berstein, Michael Rauser, Richard A. Lewis, Barron C. Fishburne, Suber Huang, Nelson R. Sabates, Nicola Kim, Robert N. Frank, Brian C. Joondeph, Odette M. Houghton, Dean P. Hainsworth, Edward Chaum, Robert H. Millay, Raymond Iezzi, Rajendra S. Apte, Ron A. Adelman, Anita Agrawal, Neelakshi Bhagat, Lawrence Ulanski, Steven D. Schwartz, Cynthia Owsley, Alan Letson, Yu-Guang He, Cynthia A. Toth, Lawrence S. Morse, Michael J. Cooney, Sandeep Grover, Henry Ferreyra, Alexander J. Brucker, David DiLoreto, Aaron Weinberg - JAMA Ophthalmology 2022 cited by 172
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Authors: Brandon Busbee, Allen C. Ho, David M. Brown, Jeffrey S. Heier, Iván J. Suñer, Zhengrong Li, Roman G. Rubio, Phillip Lai - Ophthalmology 2013 cited by 502
- Faricimab Treat-and-Extend for Diabetic Macular Edema
Authors: Tien Yin Wong, Zdenka Hašková, Kemal Asik, Caroline R. Baumal, Karl G. Csaky, Nicole Eter, Jane A. Ives, Glenn J. Jaffe, Jean‐François Korobelnik, Hugh Lin, Toshinori Murata, Paisan Ruamviboonsuk, Patricio G. Schlottmann, András Seres, David G. Silverman, Xiaodong Sun, Yannan Tang, John A. Wells, Young Hee Yoon, Charles C. Wykoff, Thomas M. Aaberg, Ashkan M. Abbey, Elmira Abdulaeva, Santiago Abengoechea, Prema Abraham, Thomas Ach, Serrhel G. Adams, Alfredo Adan Civera, Sean D. Adrean, Hansjürgen Agostini, Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel and 297 more - Ophthalmology 2023 cited by 138
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
Authors: David M. Brown, Mark Michels, Peter K. Kaiser, Jeffrey S. Heier, Judy P. Sy, Tsontcho Ianchulev - Ophthalmology 2008 cited by 1,316
- Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders
Authors: Richard F. Spaide, Chui Ming Gemmy Cheung, Hidetaka Matsumoto, Shoji Kishi, Camiel J. F. Boon, Elon H. C. van Dijk, Martine Mauget‐Faÿsse, Francine Béhar‐Cohen, M. Elizabeth Hartnett, Sobha Sivaprasad, Tomohiro Iida, David M. Brown, Jay Chhablani, Peter M. Maloca - Progress in Retinal and Eye Research 2021 cited by 360
- TENAYA and LUCERNE
Authors: Arshad M. Khanani, Aachal Kotecha, Andrew Chang, Shih‐Jen Chen, Youxin Chen, Robyn H. Guymer, Jeffrey S. Heier, Frank G. Holz, Tomohiro Iida, Jane A. Ives, Jennifer I. Lim, Hugh Lin, Stephan Michels, Carlos Quezada-Ruiz, Ursula Schmidt‐Erfurth, David G. Silverman, Rishi P. Singh, Balakumar Swaminathan, Jeffrey R. Willis, Ramin Tadayoni, Ashkan M. Abbey, Elmira Abdulaeva, Prema Abraham, Alfredo Adan Civera, Hansjürgen Agostini, Arturo Alezzandrini, Virgil Alfaro, Arghavan Almony, Lebriz Altay, Payam Amini, Andrew N. Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury S. Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline R. Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Bridges, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ik Soo Byon, Carlo Cagini, Jorge I. Calzada, Stone Cameron, Peter A. Campochiaro, John S. Carlson, Ângela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel L. Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih‐Jen Chen, San‐Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David R. Chow, Abosede Cole, B. Connolly, Pierre Loïc Cornut, Stephen Couvillion, Carl J. Danzig, Vesselin Daskalov, Amr Dessouki, François Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard F. Dreyer, Pravin U. Dugel, David Eichenbaum, Bora Eldem, Robert E. Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi S. Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip J. Ferrone, Marta S. Figueroa, Howard F. Fine, Mitchell S. Fineman, Gregory M. Fox, Catherine Français, Pablo Moreno Franco, Samantha Fraser‐Bell and 217 more - Ophthalmology 2024 cited by 179
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
Authors: Ursula Schmidt‐Erfurth, Peter K. Kaiser, Jean‐François Korobelnik, David M. Brown, Victor Chong, Quan Dong Nguyen, Allen C. Ho, Yuichiro Ogura, Christian Simader, Glenn J. Jaffe, Jason S. Slakter, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Olaf Sowade, Oliver Zeitz, Christiane Norenberg, Rupert Sandbrink, Jeffrey S. Heier - Ophthalmology 2013 cited by 811
- Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
Authors: Peter A. Campochiaro, Robert L. Avery, David M. Brown, Jeffrey S. Heier, Allen C. Ho, Stephen Huddleston, Glenn J. Jaffe, Arshad M. Khanani, Stephen Pakola, Dante J. Pieramici, Charles C. Wykoff, Sherri Van Everen - The Lancet 2024 cited by 119
- Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration
Authors: Charles C. Wykoff, David M. Brown, Kimberly Reed, Alyson J. Berliner, Adam T. Gerstenblith, Aurora Breazna, Prema Abraham, Jordana Fein, Karen Chu, W. Lloyd Clark, Sergio Leal, Thomas Schmelter, Boaz Hirshberg, George D. Yancopoulos, Robert Vitti, CANDELA Study Investigators, Suhail Alam, Astrid Gonzalez Ramos, D. Virgil Alfaro, Sean D. Adrean, John F. Payne, Harold L. Brooks, Mark Chittum, David Callanan, R. R. Paylor, Clement Chan, J. R. L. Allen, Nauman Chaudhry, Margaret Chang, Sanford Chen, William Bridges, James W. Dooner, Wayne Solley, Andrés Emanuelli, Ronald Teed, Scott M. Friedman, Nader Moinfar, Ghassan Ghorayeb, Shelly Lee, Daniel M. Berinstein, Mitchell J. Goff, Harvey Reiser, Amir Guerami, Emily D. Ashmore, Curtis Hagedorn, Jose A. Martinez, Paul Hahn, Juner Colina-Biscotto, Vrinda Hershberger, Brian C. Joondeph, Erik Kruger, J. Shepard Bryan, Michael Lee, Mark L. Chiu, C. Nathaniel Roybal, Frank Wyant, James K. Luu, Matthew Byun, James D. Palmer, Mark R. Wieland, Joel Pearlman, Evan Berger, John D. Pitcher, Rajiv Rathod, Omar S. Punjabi, Leonard Feiner, Hema L. Ramkumar, Steven Lin, Rahul Reddy, Richard F. Dreyer, Nathan Steinle, Veeral Sheth, David Faber, Cameron Stone, Robert E. Engstrom, Robert S. Wirthlin, Mahmood El-Gasim, Robert Parnes - JAMA Ophthalmology 2023 cited by 103
- Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Authors: David M. Brown, David S. Boyer, V. Diana, Charles C. Wykoff, Taiji Sakamoto, Peter H. Win, Sunir Joshi, Hani Salehi-Had, András Seres, Alyson J. Berliner, Sergio Leal, Robert Vitti, Karen Chu, Kimberly Reed, Rohini Rao, Yenchieh Cheng, Wei Sun, Delia Voronca, Rafia Bhore, Ursula Schmidt-Ott, Thomas Schmelter, Andrea Schulze, Xin Zhang, Boaz Hirshberg, George D. Yancopoulos, Sobha Sivaprasad, Prema Abraham, Christopher M. Aderman, Kunihiko Akiyama, D. Virgil Alfaro, Fareed Ali, Payam Amini, Andres Emanuelli Anzalotta, György Bátor, Ivan R. Batlle, Adam Berger, Ramanath Bhandari, William Bridges, Christian Brinkmann, Jamin S. Brown, Stuart C Burgess, Jorge I. Calzada, Antonio Capone, Dana Cervena, Steven Charles, Nauman Chaudhry, David R. Chow, W. Lloyd Clark, Paul Conrad, Matthew A. Cunningham, Hajir Dadgostar, Amr Dessouki, Dana Madison Deupree, Christopher A. Devine, David Eichenbaum, Jan Ernest, Nicolas Feltgen, M. J. Fenberg, Philip J. Ferrone, R. E. P. Frenkel, Scott M. Friedman, Julie Gasperini, Adam T. Gerstenblith, Ghassan Ghorayeb, Michel Giunta, Mitchell J. Goff, Liliya Golas, Joseph M. Googe, Jordana Fein, Curtis Hagedorn, Akira Hagiwara, Paul Hahn, Richard Hairston, Jason M. Handza, Vivienne Hau, Ken Hayashi, Jeffrey S. Heier, Vrinda Hershberger, Patrick Higgins, Yoshio Hirano, Shigeru Honda, Yasuko Ikegami, Yuichiro Ishida, Isao Ishikawa, Kiyoshi Ishii, Eric Jablon, Atul Jain, Yuichi Kaji, Kapil Kapoor, Ágnes Kerényi, Kazuhiro Kimura, Genichiro Kishino, Katalin Kiss, Takashi Kitaoka, James M. Klancnik, Namie Kobayashi, Jiro Kogo, Vladimír Korda, Erik Kruger, Sentaro Kusuhara and 55 more - The Lancet 2024 cited by 113
- KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Authors: David M. Brown, Andrés Emanuelli, Francesco Bandello, Jose Juan Escobar Barranco, João Figueira, Eric Souied, Sebastian Wolf, Vishali Gupta, Nor Fariza Ngah, Gerald Liew, Raman Tuli, Ramin Tadayoni, Dilsher Dhoot, Lixin Wang, Emmanuel Bouillaud, Ying Wang, Lidija Kovacic, Nicolas Guerard, Justus G. Garweg - American Journal of Ophthalmology 2022 cited by 168
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
Authors: David M. Brown, Quan Dong Nguyen, Dennis M. Marcus, David S. Boyer, Sunil Patel, Leonard Feiner, Patricio G. Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G. Rubio, Anthony P. Adamis, Jason S. Ehrlich, J. Jill Hopkins - Ophthalmology 2013 cited by 821
- Intravitreal Aflibercept for Diabetic Macular Edema
Authors: Jean‐François Korobelnik, V. Diana, Ursula Schmidt‐Erfurth, David S. Boyer, Frank G. Holz, Jeffrey S. Heier, Edoardo Midena, Peter K. Kaiser, Hiroko Terasaki, Dennis M. Marcus, Quan Dong Nguyen, Glenn J. Jaffe, Jason S. Slakter, Christian Simader, Yuhwen Soo, Thomas Schmelter, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Oliver Zeitz, Carola Metzig, David M. Brown - Ophthalmology 2014 cited by 807
- Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
Authors: David M. Brown, Charles C. Wykoff, David S. Boyer, Jeffrey S. Heier, W. Lloyd Clark, Andrés Emanuelli, Patrick Higgins, Michael Singer, David M. Weinreich, George D. Yancopoulos, Alyson J. Berliner, Karen Chu, Kimberly Reed, Yenchieh Cheng, Robert Vitti - JAMA Ophthalmology 2021 cited by 148
